Neoadjuvant chemotherapy with epirubicin-vinorelbine and G-CSF in locoregionally advanced breast cancer: Our experience

被引：0
|
作者：
Savarino, A. [1 ]
Fabiano, E. [1 ]
Maniaci, V [1 ]
Puliafito, I [1 ]
Sauta, M. G. [1 ]
Bene, A. [1 ]
机构：
[1] Univ Messina, Human Pathol Dept, Med Oncol & Innovat Therapies Unit, I-98100 Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Peripheral blood stem cell (PBSC) mobilization in breast cancer patients:: Chemotherapy plus G-CSF versus G-CSF alone
    Varo, MJ
    Azaceta, G
    Mayordomo, JI
    Tres, A
    Olave, T
    Moreno, JA
    Domingo, JM
    Gutiérrez, M
    Palomera, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 74 - 74
  • [42] Cisplatin-epirubicin-paclitaxel (PET) weekly administration with G-CSF support in advanced breast cancer (ABC). A phase II study
    Frasci, G
    Comella, P
    D'Aluto, G
    Apicella, A
    Thomas, R
    Capasso, I
    Carteni, G
    De Lucia, L
    Maiorino, L
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S318 - S318
  • [43] G-CSF AND G-CSF BIOSIMILARS: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN BREAST CANCER PATIENTS UNDERGOING MYELOSUPPRESSIVE CHEMOTHERAPY
    Curigliano, Giuseppe
    Botteri, Edoardo
    Krendyukov, Andriy
    BREAST, 2017, 36 : S69 - S69
  • [44] Docetaxel (TXT) monotherapy & lenograstim (G-CSF) for advanced breast cancer in the elderly
    Constenia, M
    Carrete, N
    Lorenzo, I
    García-Arroyo, FR
    Campos, B
    Rey, C
    Ozores, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S323 - S323
  • [45] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    R I Lalisang
    E E Voest
    J A Wils
    J W Nortier
    F L Erdkamp
    H F Hillen
    J Wals
    H C Schouten
    G H Blijham
    British Journal of Cancer, 2000, 82 : 1914 - 1919
  • [46] Neoadjuvant Chemotherapy with Vinorelbine-containing Regimens in Elderly Patients with Locally Advanced Breast Cancer
    Ma, Chuan-Dong
    Chen, Can-Ming
    Chen, Xiao-Song
    Liu, Guang-Yu
    Di, Gen-Hong
    Wu, Jiong
    Lu, Jin-Song
    Yang, Wen-Tao
    Chen, Jia-Yi
    Shao, Zhi-Min
    Shen, Zhen-Zhou
    Shen, Kun-Wei
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3093 - 3097
  • [47] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [48] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [49] Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer
    Lalisang, RI
    Voest, EE
    Wils, JA
    Nortier, JW
    Erdkamp, FL
    Hillen, HF
    Wals, J
    Schouten, HC
    Blijham, GH
    BRITISH JOURNAL OF CANCER, 2000, 82 (12) : 1914 - 1919
  • [50] Advanced stage gastric cancer and neoadjuvant chemotherapy Our experience in surgical resectability
    Del Rio, Paolo
    Rocchi, Marco
    Dell'Abate, Paolo
    Pucci, Francesca
    Mazzetti, Cristian
    Sianesi, Mario
    ANNALI ITALIANI DI CHIRURGIA, 2013, 84 (06) : 623 - 629
12345